-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Anxiety Provoking Hematology Consults, Second Edition

Program: Education Program
Hematology Disease Topics & Pathways:
Biological, Diseases, Combinations, Therapies, Genetic Disorders, Biological Processes, enzyme inhibitors, erythropoiesis, Clinically relevant, Myeloid Malignancies, pathogenesis, pathways
Saturday, December 5, 2020: 11:55 AM-12:00 PM

Description:
There is an array of complex and somewhat obscure conditions, seen but not always recognised by haematologists. Many of these provide enough diagnostic difficulty to meet the definition of anxiety-provoking consults. Three case-based examples of such conditions will be examined in detail.

Dr Kenneth L. McClain will unravel the mysteries of histiocytic disorders including Langerhan-cell and non-Langerhan cell types.

Dr Michael Linenberger will unravel the complexities of acute intermittent and congenital erythropoietic porphyrias.

Dr Ari Zimran will dissect why Gaucher disease is so commonly ignored in the differential diagnosis of difficult clinical scenarios.

Chair:
Jeffrey Szer, MBBS, Royal Melbourne Hospital
Disclosures:
Szer: Novartis: Consultancy, Honoraria, Speakers Bureau; Apellis: Consultancy; Alexion Pharmaceuticals Inc.: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Pfizer: Honoraria, Speakers Bureau; Takeda: Honoraria, Speakers Bureau; Prevail Therapeutics: Honoraria, Membership on an entity's Board of Directors or advisory committees.
There is an array of complex and somewhat obscure conditions, seen but not always recognised by haematologists. Many of these provide enough diagnostic difficulty to meet the definition of anxiety-provoking consults. Three case-based examples of such conditions will be examined in detail.

Dr Kenneth L. McClain will unravel the mysteries of histiocytic disorders including Langerhan-cell and non-Langerhan cell types.

Dr Michael Linenberger will unravel the complexities of acute intermittent and congenital erythropoietic porphyrias.

Dr Ari Zimran will dissect why Gaucher disease is so commonly ignored in the differential diagnosis of difficult clinical scenarios.

Kenneth L. McClain, MD, PhD

Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX

Michael Linenberger, MD

Seattle Cancer Care Alliance, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA

Ari Zimran, MD

Shaare Zedek Medical Center, Gaucher Unit, Jerusalem, Israel

See more of: Education Program